Literature DB >> 2401232

Glucocorticoid receptor messenger ribonucleic acid in different regions of human adipose tissue.

M Brönnegård1, P Arner, L Hellström, G Akner, J A Gustafsson.   

Abstract

The expression of glucocorticoid receptor (GR) messenger RNA (mRNA) was investigated in sc adipose tissue and isolated adipocytes from the abdominal and gluteal regions in men and women using a human GR complementary RNA probe. GR mRNA levels were 2-fold higher in female than in male abdominal tissue or adipocytes, whereas in gluteal tissue or adipocytes no sex differences were observed. GR mRNA levels in female abdominal adipocytes were 50% higher than in corresponding female gluteal adipocytes; the opposite was observed corresponding in males. Northern blot analysis of total cellular RNA isolated from abdominal and gluteal adipocytes showed hybridization of the human GR probe to an RNA species of approximately 7.1 kilobases in both regions. No sex or regional differences in GR mRNA stability were observed. The human metallothionein II (hMTII) mRNA, which is regulated by glucocorticoids at the transcriptional level, showed an opposite sex and regional pattern as GR mRNA. However, in gluteal adipose tissue no sex differences were observed in hMTII mRNA levels. The expression of beta-actin mRNA, which is not regulated by glucocorticoids, showed no sex or regional variation. By immunocytochemistry, using an anti-GR-monoclonal antibody, cytoplasmic as well as nuclear staining for GR was demonstrated in both sexes and both regions. In conclusion, variations in GR mRNA levels between sexes and body regions may explain the well known sex and tissue differences in effects of glucocorticoids on human adipose tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401232     DOI: 10.1210/endo-127-4-1689

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Neural Regulation of the Stress Response: The Many Faces of Feedback.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Cell Mol Neurobiol       Date:  2012-02-01       Impact factor: 5.046

2.  Depressive symptoms and change in abdominal obesity in older persons.

Authors:  Nicole Vogelzangs; Stephen B Kritchevsky; Aartjan T F Beekman; Anne B Newman; Suzanne Satterfield; Eleanor M Simonsick; Kristine Yaffe; Tamara B Harris; Brenda W J H Penninx
Journal:  Arch Gen Psychiatry       Date:  2008-12

3.  Urinary cortisol and six-year risk of all-cause and cardiovascular mortality.

Authors:  Nicole Vogelzangs; Aartjan T F Beekman; Yuri Milaneschi; Stefania Bandinelli; Luigi Ferrucci; Brenda W J H Penninx
Journal:  J Clin Endocrinol Metab       Date:  2010-08-25       Impact factor: 5.958

4.  Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.

Authors:  David E Kemp; Onur N Karayal; Joseph R Calabrese; Gary S Sachs; Elizabeth Pappadopulos; Kathleen S Ice; Cynthia O Siu; Eduard Vieta
Journal:  Eur Neuropsychopharmacol       Date:  2011-07-28       Impact factor: 4.600

5.  Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

Authors:  M Adams; C T Montague; J B Prins; J C Holder; S A Smith; L Sanders; J E Digby; C P Sewter; M A Lazar; V K Chatterjee; S O'Rahilly
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

6.  Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

Authors:  S K Fried; C D Russell; N L Grauso; R E Brolin
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Central or overall obesity: which one is a better predictor of depressive symptoms in children, adolescents, and youths?

Authors:  Samad Esmaeilzadeh; Reza Farzizadeh; Hassan-Ali Kalantari; Asghar Mahmoudi; Omid Yousefi Bilehsavar; Ali Mehranpour
Journal:  Eat Weight Disord       Date:  2016-09-21       Impact factor: 4.652

8.  11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.

Authors:  Rodrigo Muñoz; Cristian Carvajal; Alex Escalona; Camilo Boza; Gustavo Pérez; Luis Ibáñez; Carlos Fardella
Journal:  Obes Surg       Date:  2008-07-01       Impact factor: 4.129

9.  Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Rosemay A Remigio-Baker; Matthew A Allison; Pamela J Schreiner; Moyses Szklo; Rosa M Crum; Jeannie-Marie Leoutsakos; Manuel Franco; Mercedes R Carnethon; Jennifer A Nettleton; Mahasin S Mujahid; Ana V Diez Roux; Nicole Jensky; Sherita H Golden
Journal:  Psychoneuroendocrinology       Date:  2014-05-13       Impact factor: 4.905

10.  Anatomic, hematologic, and biochemical features of C57BL/6NCrl mice maintained on chronic oral corticosterone.

Authors:  Amy E Cassano; Julie R White; Kelley A Penraat; Christopher D Wilson; Skye Rasmussen; Ilia N Karatsoreos
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.